Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Depletion of Complement Enhances the Clearance of Brucella abortus in Mice

Gabriela González-Espinoza, Elías Barquero-Calvo, Esteban Lizano-González, Alejandro Alfaro-Alarcón, Berny Arias-Gómez, Esteban Chaves-Olarte, Bruno Lomonte, Edgardo Moreno, Carlos Chacón-Díaz
Craig R. Roy, Editor
Gabriela González-Espinoza
aCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elías Barquero-Calvo
bPrograma de Investigación en Enfermedades Tropicales, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elías Barquero-Calvo
Esteban Lizano-González
aCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Alfaro-Alarcón
cDepartamento de Patología, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berny Arias-Gómez
aCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esteban Chaves-Olarte
aCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Lomonte
dInstituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edgardo Moreno
bPrograma de Investigación en Enfermedades Tropicales, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica
ePrograma de Maestría en Microbiología, Química Clínica y Parasitología, Sistema de Estudios de Posgrado, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Chacón-Díaz
aCentro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Chacón-Díaz
Craig R. Roy
Yale University School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.00567-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Brucellosis is a bacterial disease of animals and humans. Brucella abortus barely activates the innate immune system at the onset of infection, and this bacterium is resistant to the microbicidal action of complement. Since complement stands as the first line of defense during bacterial invasions, we explored the role of complement in B. abortus infections. Brucella abortus-infected mice depleted of complement with cobra venom factor (CVF) showed the same survival rate as mice in the control group. The complement-depleted mice readily eliminated B. abortus from the spleen and did so more efficiently than the infected controls after 7 days of infection. The levels of the proinflammatory cytokines tumor necrosis factor alpha and interleukin-6 (IL-6) remained within background levels in complement-depleted B. abortus-infected mice. In contrast, the levels of the immune activator cytokine gamma interferon and the regulatory cytokine IL-10 were significantly increased. No significant histopathological changes in the liver and spleen were observed between the complement-depleted B. abortus-infected mice and the corresponding controls. The action exerted by Brucella on the immune system in the absence of complement may correspond to a broader phenomenon that involves several components of innate immunity.

INTRODUCTION

Brucella organisms are facultative extracellular-intracellular bacteria of animals and humans that establish chronic infections (1). Brucella abortus avoids activating the innate immune system at the onset of the infection (2–5). This phenomenon is due to the absence and modification of the Brucella pathogen-associated molecular patterns, which result in the weak activation of pattern recognition receptors (2, 3, 5–8). The lack of obvious clinical signs and symptoms at early stages of Brucella infections in animals and humans is in accordance with this model (5, 9).

The absence of polymorphonuclear leukocytes (PMNs) promotes the elimination of B. abortus in mice by favoring the Th1 over the Th2 immune response (4). This supports the proposal that innate immune recognition is hampered at the onset of the infection and that PMNs play a regulatory role in the adaptive immune response in brucellosis (4).

The complement system is a cascade of various elements of innate immunity and the first line of defense against microorganisms. Complement activation has three main functions: opsonization of invaders, amplification of the immune response through recruitment of inflammatory cells, and directing of the killing of microorganisms (10). Pathogens have developed different strategies to evade complement killing or activation (11, 12). Virulent Brucella organisms resist the killing action of complement and induce low levels of activation of the complement cascade (13–15). In spite of this, the role of complement during brucellosis in vivo has not been explored. Here, we demonstrate that the removal of complement promotes the elimination of B. abortus in mice at early times of infection, suggesting a regulatory role of this system during brucellosis.

RESULTS AND DISCUSSION

B. abortus does not kill mice depleted of complement with CVF.C3 knockout mice display innate and diverse long-lasting immunological defects (16–18) that may hamper the examination of the role of complement in brucellosis. To circumvent this, we have used the cobra venom factor (CVF) complement depletion model. CVF is a three-chain protein that structurally resembles C3c, one of the degradation products of C3b, but is unable to form a C3/C5 convertase (19). After intraperitoneal (i.p.) injection of CVF, the C3 component was not detected in the serum of mice (Fig. 1A). Complement depletion did not alter the leukocyte count or cell profiles in mice (Fig. 1B). We recorded reduced survival rates for complement-depleted mice infected with Salmonella enterica in comparison to those for the infected control group (Fig. 1C). This observation is consistent with previous works showing that CVF complement depletion in vivo exacerbates bacterial infections and lethality (20, 21). In contrast, complement-depleted mice infected with B. abortus displayed the same survival rate as B. abortus-infected control mice (Fig. 1D). Complement-depleted mice infected with B. abortus did not show any behavior changes or weight loss throughout the duration of the experiment.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

B. abortus is not lethal in complement-depleted mice. Groups of BALB/c mice were chronically depleted of complement by means of repeated injections of CVF. (A) Serum C3 detection by Western blotting was used to determine the depletion of complement (Cdepl) in CVF-injected mice. Arrows indicate the position of the C3 fraction and its fragments. (B) Percentage of leukocyte types in complement-depleted mice (n = 5) and PBS-injected control mice (n = 5). Lymph, lymphocytes; Mono, monocytes. (C) Survival percentage of PBS-injected control mice (n = 7) and complement-depleted mice (n = 7) after infection with S. enterica. (D) Survival percentage of PBS-injected control mice (n = 7) and complement-depleted mice (n = 7) after infection with B. abortus 2308W. Black and white bars represent the median ± interquartile range (IQR). The Mann-Whitney U test showed no significant differences. Data are representative of those from at least three independent experiments.

The absence of complement favors the removal of B. abortus.In order to determine if the acute absence of complement alters the course of Brucella infection, we performed bacterial counts in the spleen. As demonstrated in Fig. 2A, the spleen weights were not statistically significantly different between the complement-depleted and control B. abortus-infected mice (Fig. 2A). In contrast, the number of bacteria in the spleens of complement-depleted infected mice was significantly lower than that in the spleens of the control infected group (Fig. 2B). As shown in Fig. 2C and D, we did not detect differences in spleen weights or bacterial clearance between the aspercetin-treated and B. abortus-infected mice and the phosphate-buffered saline (PBS)-treated control mice. This result is consistent with our previous experience demonstrating that the repeated administration of a sole foreign immunogenic protein does not alter the course of B. abortus infection in mice (22), therefore ruling out an adjuvant effect by the early induction of the adaptive immune response.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

The absence of complement favors the removal of B. abortus. (A) Groups of seven BALB/c mice were depleted of complement or injected with PBS and then infected with 0.1 ml of B. abortus 2308W at 106 CFU/ml by the i.p. route. At 7 days postinfection, the spleen weight and bacterial counts were determined for each group. (B) To ensure that CVF did not prime an adjuvant immune response, promoting bacterial clearance, groups of seven BALB/c mice were treated with repeated i.p. injections of 80 μg of aspercetin or with PBS and then infected with 0.1 ml of B. abortus 2308W at 106 CFU/ml by the i.p. route. (C and D) At 7 days postinfection the spleen weight (C) and bacterial counts (D) were determined for each group. The median is represented by a line. Statistical significance was calculated by the Mann-Whitney U test. *, P < 0.05. Data are representative of those from at least three independent experiments.

Complement-depleted B. abortus-infected mice produce higher levels of proinflammatory cytokines.In order to evaluate the proinflammatory response of complement-depleted Brucella-infected mice after 7 days of infection, quantitation of cytokines was performed (Fig. 3). The amounts of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) remained close to the background levels. In contrast, the quantities of gamma interferon (IFN-γ) as well as the regulatory cytokine IL-10 were significantly higher in the infected complement-depleted mice (Fig. 3). This cytokine profile is similar to the one induced in Brucella-infected mice depleted of PMNs (4).

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Complement-depleted B. abortus-infected mice produce higher levels of proinflammatory cytokines. Cytokine levels in sera from complement-depleted (n = 7) and control (n = 7) mice were determined by ELISA after 7 days of infection with 0.1 ml of B. abortus 2308W (Ba 2308) at 106 CFU/ml by the i.p. route. A group of noninfected complement-depleted mice (n = 5) was used as a control. The mean is represented as a line. Asterisks above the bars indicate statistically significant differences relative to complement-depleted noninfected mice. Statistical significance was calculated by ANOVA and Tukey's multiple-comparison test. **, P < 0.01; ***, P < 0.001. Data are representative of those from at least three independent experiments.

Complement depletion does not influence the pathology in B. abortus-infected mice.As expected, S. enterica, used for comparative purposes, induced a severe acute inflammation in the spleen and liver of complement-depleted mice at 7 days of infection (Fig. 4A). In contrast, B. abortus-infected complement-depleted mice demonstrated chronic inflammation with granuloma formation (Fig. 4B) indistinguishable from that in B. abortus-infected mice not depleted of complement (Fig. 4A). Although little vasodilation and hyperemia were observed in the liver and spleen of noninfected C3-depleted mice, the histopathological effect observed in the B. abortus-infected mice was not due to the action of CVF (Fig. 4A).

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Complement-depleted B. abortus-infected mice show a histopathological profile similar to that of the control PBS-injected B. abortus-infected mice. (A) The semiquantitative pathological index was determined by histopathological observation of the spleen and liver from complement-depleted mice (n = 7) and control mice (n = 7) after 7 days of infection with 0.1 ml of 106 B. abortus bacteria or 3 days of infection with 103 S. enterica bacteria. (B) Histopathological examination of the liver and spleen of complement-depleted B. abortus-infected mice after 7 days of infection. The arrows indicate the characteristic granulomas induced by Brucella in the liver and spleen (35). Data are representative of those from at least three independent experiments.

At the onset of infection, Brucella follows a stealthy strategy, taking advantage of an immunological window to invade the host cells and disperse throughout the reticuloendothelial system (1, 3, 5). During infection, Brucella interacts with a variety of serum proteins, such as antibodies and complement components, that selectively bind to the bacterium surface (22). Regardless of this, Brucella resists the killing action of complement and does not fully activate the complement cascade (13–15). Interestingly, these two complement activities vary depending upon the animal species: human serum opsonizes better and is more bactericidal than mouse serum (22). In spite of this, complement still plays a relevant role in vivo in the mouse model during the acute phase of Brucella infection, as shown here. From our results, we propose that Brucella hampers the opsonizing, killing, and chemotactic functions of complement by C3 convertase modulation and does so independently if activation is related to the alternative pathway at the onset of the infection or if activation is related to the classical pathway in later stages to sustain persistence.

It is worth noting the parallelism observed between the complement depletion model, used in this work, and the PMN depletion model, used previously during B. abortus infections (4). Indeed, in both murine models, the cytokine profile is similar and B. abortus is more efficiently eliminated from the spleen. It seems that in both systems, the regulatory mechanism of the adaptive immune response during brucellosis is released after removal of complement or PMNs (4). This is not totally unexpected, since both elements cross talk during the innate immune response (23).

Bacterial infections inducing low inflammatory responses (as is the case in brucellosis) drive the production of IL-10 by naturally occurring regulatory T cells (nTregs) (24). In the course of the infection, this allows pathogens to escape from the immune control, preventing pathology and favoring pathogen persistence (24). It may be that the Brucella-infected complement-depleted mice induced adaptive nTregs with the ability to promote the synthesis of IFN-γ, IL-12, and IL-10. Moreover, it is well-known that complement depletion hampers the arrival of inflammatory cells, including PMNs, in injured animals (25). Therefore, complement and PMNs are key components of innate immunity, and the efficient removal of B. abortus from the spleen of complement-depleted mice and PMN-depleted mice may be due to the higher levels of production of IFN-γ and IL-12, which are the most relevant cytokines in brucellosis (26). Interestingly, mice lacking B cells, which are mainly elements of the adaptive immune response, also favor the removal of Brucella by increasing IFN-γ levels (27). This particular immune response may favor the positive balance of the Th1 immune response and the suppression of downstream pathologies, as seen for other microbes (28, 29). This proposal is in tune with our previous proposal resulting from findings obtained with the PMN depletion model (4). Although we do not know the mechanism exerted by Brucella, it seems that it corresponds to a broader phenomenon that involves several components of the innate immune system.

MATERIALS AND METHODS

Ethics statement.The protocols for mouse experimentation were approved by the Comité Institucional para el Cuido y Uso de los Animales of the Universidad de Costa Rica (CICUA-019-16, CICUA-067-17). These protocols were in agreement with the corresponding law, Ley de Bienestar de los Animales, of Costa Rica (Law 9458 on animal welfare). Mice were housed in the Animal Building of the Veterinary Medicine School, Universidad Nacional, Costa Rica. All of the animals were kept in cages with water and food ad libitum under biosafety containment conditions before and during the experiment.

Mouse strains and infection protocols.CVF was purified from the venom of the Naja naja cobra as described elsewhere (30). Female BALB/c mice (weight, 18 to 21 g) were depleted of complement by intraperitoneal (i.p.) injection of CVF at 0.8 μg/g body weight/mouse in 0.1 ml PBS (20) following the protocol described in Fig. 5. Controls and complement-depleted mice were i.p. infected with 0.1 ml of PBS containing 106 CFU/ml of the virulent strain B. abortus 2308W (31) or 103 CFU of Salmonella enterica serovar Typhimurium strain SL1344 (Fig. 5). A group of mice was injected with CVF only to ensure that the effects seen in infected mice were not only due to the CVF injection. Controls were injected with 0.1 ml sterile PBS. Complement depletion was confirmed by the absence of the C3 protein by Western blotting using polyclonal C3 antibody (catalog number ab14232; Abcam) in combination with goat anti-mouse IgG (H+L)-horseradish peroxidase for detection (Thermo Fisher Scientific). Complement depletion was continued for 7 and 10 days after infection, as indicated in the time course protocol presented in Fig. 5.

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

Protocol for depletion of complement with CVF in mice. CVF (0.8 μg/g body weight) was administered intraperitoneally at different times before and after bacterial infections (thin arrows). Bacteria were inoculated at time zero (broken arrow). Bacterial counts, cytokine estimation, and histopathological studies were performed at 7 days of infection (bent arrow). The end of the survival experiment is indicated with a thick arrow.

Heat-inactivated CVF is not a suitable antigenic control. Like many other proteins related to complement, the CVF protein is thermolabile and breaks down into many small peptides with low immunogenicity. Therefore, to ensure that the immune response adjuvant effect against a foreign protein was not promoting B. abortus clearance, a second group of mice was treated with aspercetin, a low-molecular-weight protein from the venom of the Bothrops asper snake that depletes platelets via the de Hageman factor (32). Briefly, BALB/c mice were depleted through the i.p. injection of 80 μg of purified aspercetin protein in 0.1 ml PBS. Then, platelet-depleted mice were i.p. infected with 0.1 ml of PBS containing 106 CFU/ml of virulent Brucella abortus 2308W at 6 h after depletion. Platelet-depleted mice were again i.p. injected with the same dose of aspercetin at 24 and 48 h postinfection. Controls were injected with 0.1 ml sterile PBS. A group of mice was injected with aspercetin only to ensure that the effects seen in infected mice were not due to the injection of aspercetin. Platelet depletion was confirmed with a VetScan HM5 hematology analyzer (Abaxis). Mice were sacrificed at 7 days postinfection to perform CFU counts.

Bacterial counts, cytokine quantitation, and histopathology.Spleens were collected, weighed, and homogenized in sterile PBS, and bacterial counts were estimated as described elsewhere (33). Blood was collected from the mice, and serum was kept at −80°C until it was used. Murine levels of IL-6, IL-10, IL-12, IFN-γ, and TNF-α were measured using mouse enzyme-linked immunosorbent assay (ELISA) Ready-Set-Go! kits (Affymetrix; eBioscience) according to the manufacturer's specifications. A pool of serum from healthy BALB/c mice was used for background estimation. For histopathological studies, the spleens and livers of the mice were fixed in 10% neutral buffered formalin, processed, stained with hematoxylin and eosin or Giemsa stain as described elsewhere (34), and then observed under a microscope.

Statistical analysis.We used GraphPad Prism software (La Jolla, CA, USA) to statistically analyze our results. The Mann-Whitney test was used for comparison of the cell profiles of mice that had been complement depleted with CVF and control mice, as well as the spleen weights and CFU of complement-depleted or platelet-depleted and control Brucella-infected mice. Analysis of variance (ANOVA) followed by Tukey's multiple-comparison test was used for comparison of cytokine levels among mice complement depleted with CVF, complement-depleted mice, and control Brucella-infected mice. P values of <0.05 were considered to represent a statistically significant difference.

ACKNOWLEDGMENTS

We thank Alexandra Rucavado, Instituto Clodomiro Picado, University of Costa Rica, for providing purified aspercetin for the platelet depletion assays.

This work was funded by Fondo Especial de Estímulo, Vice-Presidency for Research, University of Costa Rica, project 803-B0-601 (www.vinv.ucr.ac.cr); Fondo UCREA, University of Costa Rica, project 803-B8-762 (www.ucrea.ucr.ac.cr); and the International Centre for Genetic Engineering and Biotechnology (contract CRP/16/005) (www.icgeb.trieste.it).

The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

FOOTNOTES

    • Received 20 July 2018.
    • Accepted 30 July 2018.
    • Accepted manuscript posted online 6 August 2018.

REFERENCES

  1. 1.↵
    1. Moreno E,
    2. Moriyón I
    . 2006. The genus Brucella, p 315–456. In Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrant E. (ed), The prokaryotes, vol 5. Springer Verlag, New York, NY.
  2. 2.↵
    1. Barquero-Calvo E,
    2. Chaves-Olarte E,
    3. Weiss D,
    4. Guzmán-Verri C,
    5. Chacón-Díaz C,
    6. Rucavado A,
    7. Moriyón I,
    8. Moreno E
    . 2007. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2:e631. doi:10.1371/journal.pone.0000631.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Martirosyan A,
    2. Moreno E,
    3. Gorvel JP
    . 2011. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev 240:211–234. doi:10.1111/j.1600-065X.2010.00982.x.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Barquero-Calvo E,
    2. Martirosyan A,
    3. Ordoñez-Rueda D,
    4. Arce-Gorvel V,
    5. Alfaro-Alarcón A,
    6. Lepidi H,
    7. Malissen M,
    8. Gorvel JP,
    9. Moreno E
    . 2013. Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. PLoS Pathog 9:e1003167. doi:10.1371/journal.ppat.1003167.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Chacón-Díaz C,
    2. Altamirano-Silva P,
    3. González-Espinoza G,
    4. Medina M-C,
    5. Alfaro-Alarcón A,
    6. Bouza-Mora L,
    7. Wong M,
    8. Barquero-Calvo E,
    9. Rojas N,
    10. Guzmán-Verri C,
    11. Moreno E,
    12. Chaves-Olarte E
    . 2015. Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts. Infect Immun 83:4861–4870. doi:10.1128/IAI.00995-15.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Barquero-Calvo E,
    2. Conde-Álvarez R,
    3. Chacón-Díaz C,
    4. Quesada-Lobo L,
    5. Martirosyan A,
    6. Guzmán-Verri C,
    7. Iriarte M,
    8. Mancek-Keber M,
    9. Jerala R,
    10. Gorvel JP,
    11. Moriyón I,
    12. Moreno E,
    13. Chaves-Olarte E
    . 2009. The differential interaction of Brucella and Ochrobactrum with immunity reveals traits related to the evolution of stealthy pathogens. PLoS One 4:e5893. doi:10.1371/journal.pone.0005893.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Palacios-Chaves L,
    2. Conde-Álvarez R,
    3. Gil-Ramírez Y,
    4. Zúñiga-Ripa A,
    5. Barquero-Calvo E,
    6. Chacón-Díaz C,
    7. Chaves-Olarte E,
    8. Arce-Gorvel V,
    9. Gorvel JP,
    10. Moreno E,
    11. de Miguel MJ,
    12. Grilló MJ,
    13. Moriyón I,
    14. Iriarte M
    . 2011. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern. PLoS One 6:e16030. doi:10.1371/journal.pone.0016030.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Conde-Álvarez R,
    2. Arce-Gorvel V,
    3. Iriarte M,
    4. Mancek-Keber M,
    5. Barquero-Calvo E,
    6. Palacios-Chaves L,
    7. Chacón-Díaz C,
    8. Chaves-Olarte E,
    9. Martirosyan A,
    10. von Bargen K,
    11. Grilló MJ,
    12. Jerala R,
    13. Brandenburg K,
    14. Llobet E,
    15. Bengoechea JA,
    16. Moreno E,
    17. Moriyón I,
    18. Gorvel JP
    . 2012. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog 8:e1002675. doi:10.1371/journal.ppat.1002675.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Ariza J
    . 1999. Brucellosis an update. The perspective from the Mediterranean Basin. Rev Med Microbiol 10:125–135.
    OpenUrl
  10. 10.↵
    1. Murphy K,
    2. Travers P,
    3. Walport M,
    4. Janeway C
    . 2012. Janeway's immunobiology, 8th ed. Garland Science, New York, NY.
  11. 11.↵
    1. Lambris JD,
    2. Ricklin D,
    3. Geisbrecht BV
    . 2008. Complement evasion by human pathogens. Nat Rev Microbiol 6:132–142. doi:10.1038/nrmicro1824.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Blom AM,
    2. Hallström T,
    3. Riesbeck K
    . 2009. Complement evasion strategies of pathogens—acquisition of inhibitors and beyond. Mol Immunol 46:2808–2817. doi:10.1016/j.molimm.2009.04.025.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Eisenschenk FC,
    2. Houle JJ,
    3. Hoffmann EM
    . 1995. Serum sensitivity of field isolates and laboratory strains of Brucella abortus. Am J Vet Res 56:1592–1598.
    OpenUrlPubMed
  14. 14.↵
    1. Eisenschenk FC,
    2. Houle JJ,
    3. Hoffmann EM
    . 1999. Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol 68:235–244. doi:10.1016/S0378-1135(99)00075-9.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Fernández-Prada CM,
    2. Nikolich M,
    3. Vemulapalli R,
    4. Sriranganathan N,
    5. Boyle SM,
    6. Schurig GG,
    7. Hadfield TL,
    8. Hoover DL
    . 2001. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect Immun 69:4407–4416. doi:10.1128/IAI.69.7.4407-4416.2001.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Zhou W,
    2. Patel H,
    3. Li K,
    4. Peng Q,
    5. Villiers M,
    6. Sacks S
    . 2006. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107:2461–2469. doi:10.1182/blood-2005-08-3144.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Ruan C,
    2. Ge Q,
    3. Li Y,
    4. Li X,
    5. Chen D,
    6. Ji K,
    7. Wu Y,
    8. Sheng L,
    9. Yan C,
    10. Zhu D,
    11. Gao P
    . 2015. Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice. Arterioscler Thromb Vasc Biol 35:598–606. doi:10.1161/ATVBAHA.114.304927.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Rogińska D,
    2. Kawa MP,
    3. Pius-Sadowska E,
    4. Lejkowska R,
    5. Łuczkowska K,
    6. Wiszniewska B,
    7. Kaarniranta K,
    8. Paterno J,
    9. Schmidt C,
    10. Machaliński B,
    11. Machalińska A
    . 2017. Depletion of the third complement component ameliorates age dependent oxidative stress and positively modulates autophagic activity in aged retinas in a mouse model. Oxid Med Cell Longev 2017:5306790. doi:10.1155/2017/5306790.
    OpenUrlCrossRef
  19. 19.↵
    1. Vogel C,
    2. Fritzinger DC
    . 2010. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon 56:1198–1222. doi:10.1016/j.toxicon.2010.04.007.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Sakiniene E,
    2. Bremell T,
    3. Tarkowski A
    . 1999. Complement depletion aggravates Staphylococcus aureus septicemia and septic arthritis. Clin Exp Immunol 115:95–102. doi:10.1046/j.1365-2249.1999.00771.x.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Younger JG,
    2. Shankar-Sinha S,
    3. Mickiewicz M,
    4. Brinkman AS,
    5. Valencia GA,
    6. Sarma JV,
    7. Younkin EM,
    8. Standiford TJ,
    9. Zetoune FS,
    10. Ward PA
    . 2003. Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia. Am J Respir Cell Mol Biol 29:432–438. doi:10.1165/rcmb.2002-0145OC.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mora-Cartín R,
    2. Chacón-Díaz C,
    3. Gutiérrez-Jiménez C,
    4. Gurdián-Murillo S,
    5. Lomonte B,
    6. Chaves-Olarte E,
    7. Barquero-Calvo E,
    8. Moreno E
    . 2016. N-Formyl-perosamine surface homopolysaccharides hinder the recognition of Brucella abortus by mouse neutrophils. Infect Immun 84:1712–1721. doi:10.1128/IAI.00137-16.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Camous L,
    2. Roumenina L,
    3. Bigot S,
    4. Brachemi S,
    5. Frémeaux-Bacchi V,
    6. Lesavre P,
    7. Halbwachs-Mecarelli L
    . 2011. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 117:1340–1349. doi:10.1182/blood-2010-05-283564.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Couper K,
    2. Blount D,
    3. Riley E
    . 2008. IL-10: the master regulator of immunity to infection. J Immunol 180:5771–5777. doi:10.4049/jimmunol.180.9.5771.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Wahl S,
    2. Arend W,
    3. Ross R
    . 1974. The effect of complement depletion on wound healing. Am J Pathol 74:73–90.
    OpenUrl
  26. 26.↵
    1. Baldwin C,
    2. Goenka R
    . 2004. Host cellular immune responses against Brucella spp evaluated using the mouse model, p 341–367. In López-Gõni I, Moriýon I (ed), Brucella: molecular and cellular biology. Horizon Bioscience, Norfolk, United Kingdom.
  27. 27.↵
    1. Goenka R,
    2. Parent MA,
    3. Elzer PH,
    4. Baldwin CL
    . 2011. B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. J Infect Dis 203:1136–1146. doi:10.1093/infdis/jiq171.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Anderson CF,
    2. Oukka M,
    3. Kuchroo VJ,
    4. Sacks D
    . 2007. CD4(+)CD25(−)Foxp3(−) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285–297. doi:10.1084/jem.20061886.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Jankovic D,
    2. Kullberg MC,
    3. Feng CG,
    4. Goldszmid RS,
    5. Collazo CM,
    6. Wilson M,
    7. Wynn TA,
    8. Kamanaka M,
    9. Flavell RA,
    10. Sher A
    . 2007. Conventional T-bet(+)Foxp3(−) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204:273–283. doi:10.1084/jem.20062175.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Vogel CW,
    2. Müller-Eberhard HJ
    . 1984. Cobra venom factor: improved method for purification and biochemical characterization. J Immunol Methods 73:203–220. doi:10.1016/0022-1759(84)90045-0.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Suárez-Esquivel M,
    2. Ruiz-Villalobos N,
    3. Castillo-Zeledón A,
    4. Jiménez-Rojas C,
    5. Roop RM, II,
    6. Comerci DJ,
    7. Barquero-Calvo E,
    8. Chacón-Díaz C,
    9. Caswell CC,
    10. Baker KS,
    11. Chaves-Olarte E,
    12. Thomson NR,
    13. Moreno E,
    14. Letesson JJ,
    15. De Bolle X,
    16. Guzmán-Verri C
    . 2016. Brucella abortus strain 2308 Wisconsin genome: importance of the definition of reference strains. Front Microbiol 7:1557.
    OpenUrl
  32. 32.↵
    1. Rucavado A,
    2. Soto M,
    3. Kamiguti AS,
    4. Theakston RD,
    5. Fox JW,
    6. Escalante T,
    7. Gutiérrez JM
    . 2001. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage. Thromb Haemost 85:710–715. doi:10.1055/s-0037-1615657.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Barquero-Calvo E,
    2. Chacón-Díaz C,
    3. Chaves-Olarte E,
    4. Moreno E
    . 2013. Bacterial counts in spleen. Bio-Protocol 3:e954. doi:10.21769/BioProtoc.954.
    OpenUrlCrossRef
  34. 34.↵
    1. Aughey E,
    2. Frye FL
    . 2001. Comparative veterinary histology: with clinical correlates. Manson Publishing, London, United Kingdom.
  35. 35.↵
    1. Grilló MJ,
    2. Blasco JM,
    3. Gorvel JP,
    4. Moriyón I,
    5. Moreno E
    . 2012. What have we learned from brucellosis in the mouse model? Vet Res 43:29. doi:10.1186/1297-9716-43-29.
    OpenUrlCrossRefPubMed
  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

PreviousNext
Back to top
Download PDF
Citation Tools
Depletion of Complement Enhances the Clearance of Brucella abortus in Mice
Gabriela González-Espinoza, Elías Barquero-Calvo, Esteban Lizano-González, Alejandro Alfaro-Alarcón, Berny Arias-Gómez, Esteban Chaves-Olarte, Bruno Lomonte, Edgardo Moreno, Carlos Chacón-Díaz
Infection and Immunity Sep 2018, 86 (10) e00567-18; DOI: 10.1128/IAI.00567-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Depletion of Complement Enhances the Clearance of Brucella abortus in Mice
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Depletion of Complement Enhances the Clearance of Brucella abortus in Mice
Gabriela González-Espinoza, Elías Barquero-Calvo, Esteban Lizano-González, Alejandro Alfaro-Alarcón, Berny Arias-Gómez, Esteban Chaves-Olarte, Bruno Lomonte, Edgardo Moreno, Carlos Chacón-Díaz
Infection and Immunity Sep 2018, 86 (10) e00567-18; DOI: 10.1128/IAI.00567-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS AND DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Brucella
Brucella abortus
brucellosis
complement
cobra venom factor
innate immunity

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522